Page 6«..5678..2030..»

Nanotechnology Based Approaches For Combating COVID-19 Could Fast-Track New Detection Modalities And Treatments – PRNewswire

§ November 12th, 2020 § Filed under Nanotech Comments Off on Nanotechnology Based Approaches For Combating COVID-19 Could Fast-Track New Detection Modalities And Treatments – PRNewswire

PALM BEACH, Fla., Nov. 11, 2020 /PRNewswire/ --Academia and industry around the world are working from basic research to advanced technology to alleviate the effects of the COVID19 health crisis. The application of nanoscience and nanotechnology concepts and tools is a good approach within the current global priority. Nanomedicine may provide the fastest-track to the multitude of health issues that are embodied in the global pandemic. Nanotechnology is a common term for nanoscale science, engineering and technology, which offers extraordinary economic and technological benefits. Healthcare is one of the most prominent field of research in nanotechnology. Nanomedicine can be understood as a field of diagnosing, treating and preventing disease using molecular tools and knowledge of the human body. Nanomedicine can address many essential medical problems by using nanomaterials and by obtaining clarity on their interaction with biological systems. Nanomedicine products have various potential applications such as in drug delivery, in vivo imaging, in vitro diagnostics, regenerative medicine, dental, medical devices, and dermal applications. Researchers are turning to nanotechnology to look for answers.Active Biotechs in the markets today include: NanoViricides, Inc. (NYSE: NNVC), Inovio Pharmaceuticals, Inc. (NASDAQ: INO), Altimmune, Inc. (NASDAQ: ALT), Eli Lilly and Company's(NYSE: LLY), Pfizer Inc. (NYSE: PFE).

One industry publication (IOPScience) during a report focused on nanotechnology said: "The novel coronavirus pneumonia pandemic was declared as 'public-health emergency of international concern' by the World Health Organization on 30 January 2020. The sudden emergence has triggered alarm for instant management using anti-viral measures and diagnostic tools Taking into consideration the current severity of this disease and the imperative need of SARS-CoV-2 specific treatment and diagnostic tools, nanotechnology-based approaches can provide promising alternatives to conventional ways of disease diagnosis, treatment, and preventing exposure to SARS-CoV-2."

NanoViricides, Inc. (NYSE American: NNVC) Breaking News: NanoViricides Has Engaged Calvert Labs for Safety Pharmacology Studies of Its Drug for the Treatment of COVID-19 NanoViricides, a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today reported that it has engaged Calvert Labs, a contract research organization ("CRO"), for performing the Safety Pharmacology studies of its clinical drug candidate for the treatment of COVID-19.

The Company has been diligently working on advancing its drug candidates for the treatment of COVID-19 towards human clinical trials as rapidly as feasible.

The Company intends to perform certain core safety pharmacology studies to ensure safety of the drug candidates at Calvert Labs. The data from these studies will be used for filing an IND application. Prior to that, the Company also intends to file a pre-IND application with the U.S. Food and Drug Administration ("FDA") to obtain guidance.

The recent increase in COVID-19 cases worldwide has led scientists to suggest that this pandemic virus is expected to become a circulating virus. Influenza viruses and common cold viruses are other examples of circulating viruses. However, SARS-CoV-2 is more virulent, and thereby causes substantially greater morbidity and mortality than these other circulating viruses. Therefore, development of an effective drug to treat the disease caused by SARS-CoV-2 is very important.

A curative treatment for a virus such as SARS-CoV-2 coronavirus would require a multi-faceted attack that shuts down (i) the ability of the virus to infect host cells and simultaneously and (ii) the ability of the virus to multiply inside the host cells. The nanoviricide platform enables direct multi-point attack on the virus that is designed to disable the virus and its ability to infect new cells. At the same time, a nanoviricide is also capable of carrying payload in its "belly" (inside the micelle) that can be chosen to affect the ability of the virus to replicate. The nanoviricide is designed to protect the payload from metabolism in circulation. Thus, the nanoviricide platform provides an important opportunity to develop a curative treatment against SARS-CoV-2, the cause of COVID-19 spectrum of pathologies. Read the full press release by going to: http://www.nanoviricides.com/companynews.html

In other biotech news in the markets this week:

INOVIO (NASDAQ: INO) a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, this week reported financial results for the quarter ended September 30, 2020. INOVIO's management will host a live conference call and webcast at 4:30 p.m. Eastern Standard Time today to discuss financial results and provide a general business update, including near-term expectations for its COVID-19 DNA vaccine development program and a clinical program update for its DNA medicines portfolio. The live webcast and a replay may be accessed by visiting INOVIO's website at http://ir.inovio.com/events-and-presentations/default.aspx.

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, recently announced that it entered into an agreement with Lonza for the manufacturing of AdCOVID, Altimmune's next-generation, single-dose intranasal vaccine candidate for COVID-19. Lonza is a leading global biopharmaceutical manufacturing company with facilities in Europe, North America, and South Asia.

Alberto Santagostino, SVP, Head of Cell and Gene Technologies for Lonza, commented, "We are deeply committed to fighting this global pandemic and deploying our expertise and resources to help vaccine developers like Altimmune meet commercial manufacturing requirements for novel and promising vaccine candidates. Lonza is proud to be well-positioned to support these companies in their mission to serve such critical public health needs."

The U.S. Food and Drug Administration (FDA) recently granted Emergency Use Authorization (EUA) for Eli Lilly and Company's (NYSE: LLY) investigational neutralizing antibody bamlanivimab (LY-CoV555) 700 mg. Bamlanivimab is authorized for the treatment of mild to moderate COVID-19 in adults and pediatric patients 12 years and older with a positive COVID-19 test, who are at high risk for progressing to severe COVID-19 and/or hospitalization. Bamlanivimab should be administered as soon as possible after a positive COVID-19 test and within 10 days of symptom onset. The authorization allows for the distribution and emergency use of bamlanivimab, which is administered via a single intravenous infusion.

Pfizer Inc. (NYSE: PFE) and BioNTech SE (BNTX) this week announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study.

After discussion with the FDA, the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases. Upon the conclusion of those discussions, the evaluable case count reached 94 and the DMC performed its first analysis on all cases. The case split between vaccinated individuals and those who received the placebo indicates a vaccine efficacy rate above 90%, at 7 days after the second dose.

DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM was compensated twenty five hundred dollars for news coverage of current press release issued by NanoViricides, Inc. by a non-affiliated third party.FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:

Media Contact email: [emailprotected] +1(561)325-8757

SOURCE FinancialNewsMedia.com

The rest is here:

Nanotechnology Based Approaches For Combating COVID-19 Could Fast-Track New Detection Modalities And Treatments - PRNewswire

Read the Rest...

Insights on the Nanotechnology for Food Packaging Global Market Analysis and Forecast to 2025 – GlobeNewswire

§ November 12th, 2020 § Filed under Nanotech Comments Off on Insights on the Nanotechnology for Food Packaging Global Market Analysis and Forecast to 2025 – GlobeNewswire

November 10, 2020 07:43 ET | Source: Research and Markets

Dublin, Nov. 10, 2020 (GLOBE NEWSWIRE) -- The "Nanotechnology for Food Packaging Market - A Global Market and Regional Analysis: Focus on (Product, Application, Industry Outlook, Region and Country Analysis) - Analysis and Forecast, 2019-2025" report has been added to ResearchAndMarkets.com's offering.

The packaging industry is in the process of constant evolution, with various technological developments taking place in the industry that have enhanced features in packaging materials to make the food consumption experience better. The growing demand for food types and varieties of exotic foodstuffs leads to the complications for safer and more secure packaging of goods, which advances the concept of food packaging in the industry.

The rise of nanotechnology has accelerated the evolution of packaging present in the food industry. The packaging today has become the latest focus for food manufacturers, as they have to advance themselves in comparison to the new packaging material that acts as a part of branding and certifies food safety. An inevitable evolution is nanotechnology incorporated in food packaging, such as active packaging, improved packaging, and an upcoming category of smart/intelligent packaging that has sensors embedded in the packaging itself, which provides abundant data for suppliers to track than what today's packaging can offer.

The upcoming trends and opportunities in the nanotechnology application in food packaging sector are expected to be at the forefront in the coming decade, with blockchain application in food packaging becoming the most prominent in the field.

The exponential rise in the adoption of nanotechnology for food packaging on the global level has created a buzz among companies to invest in this industry.

On the basis of region, North America holds the largest share of nanotechnology for food packaging sold in terms of value, due to high awareness and product availability in the region. Apart from this, South America is anticipated to grow at the fastest CAGR during the forecast period.

Key Companies Profiled

Amcor Ltd., Sonoco Products Company, BASF SE, Tetra Laval International S.A., Honeywell International Inc., and Chevron Phillips Chemical Company, LLC, among others

Key Questions Answered in this Report:

Key Topics Covered:

1 Markets 1.1 Industry Outlook 1.1.1 Nanotechnology for Food Packaging: Overview 1.1.1.1 Timeline: Evolution of Food Packaging 1.1.1.2 Emergence of Nanotechnology in Food 1.1.2 Ecosystem Participants 1.1.3 Futuristic Trends 1.1.3.1 Blockchain in Food Packaging 1.2 Business Dynamics 1.2.1 Business Drivers 1.2.1.1 Need for Food Safety for the Consumers 1.2.1.2 Extended Shelf Life of Products 1.2.2 Business Challenges 1.2.2.1 Impact of COVID-19 on Raw Material Providers 1.2.3 Business Strategies 1.2.3.1 Product Development and Innovation 1.2.3.2 Market Developments 1.2.4 Corporate Strategies 1.2.4.1 Partnerships, Collaborations, Mergers and Acquisitions, and Joint Ventures 1.2.5 Business Opportunities 1.2.5.1 Nano-Printed Intelligent Food packaging

2 Application 2.1 Application and Specification 2.1.1 Fruits and Vegetables 2.1.2 Beverages 2.1.3 Prepared Foods 2.1.4 Meat Products 2.1.5 Bakery Products 2.2 Demand Analysis of Nanotechnology for Food Packaging (by Application) 2.2.1 Fruits and Vegetables 2.2.1.1 Demand Analysis of Fruits and Vegetables Nanotechnology for Food Packaging Market by Region 2.2.2 Beverages 2.2.2.1 Demand Analysis of Beverages Nanotechnology for Food Packaging Market by Region 2.2.3 Prepared Foods 2.2.3.1 Demand Analysis of Prepared Foods Nanotechnology for Food Packaging Market by Region 2.2.4 Meat Products 2.2.4.1 Demand Analysis of Meat Products Nanotechnology for Food Packaging Market by Region 2.2.5 Bakery Products 2.2.5.1 Demand Analysis of Bakery Products Nanotechnology for Food Packaging Market by Region

3 Products 3.1 Global Nanotechnology for Food Packaging Market (by Product) 3.1.1 Active Packaging 3.1.2 Improved Packaging 3.1.3 Smart/Intelligent Packaging 3.2 Demand Analysis of Nanotechnology for Food Packaging Market (by Technology) 3.2.1 Active Packaging 3.2.1.1 Demand Analysis of Active Packaging Market (by Region) 3.2.2 Improved Packaging 3.2.2.1 Demand Analysis of Improved Packaging Market (by Region) 3.2.3 Smart/Intelligent Packaging 3.2.3.1 Demand Analysis of Smart/Intelligent Packaging Market (by Region)

4 Regions 4.1 North America 4.2 South America 4.3 Europe 4.4 U.K. 4.5 Middle East and Africa 4.6 China 4.7 Asia-Pacific and Japan

5 Markets - Competitive Benchmarking & Company Profiles 5.1 Competitive Benchmarking 5.2 Amcor Plc 5.2.1 Company Overview 5.2.1.1 Role of Amcor Plc in Nanotechnology for Food Packaging Market 5.2.1.2 Product Portfolio 5.2.1.3 Production Sites 5.2.2 Business Strategies 5.2.2.1 Product Development 5.2.2.2 Market Development 5.2.3 Corporate Strategies 5.2.3.1 Partnership and Collaboration 5.2.3.2 Merger and Acquisition 5.2.4 Strength and Weakness of Amcor Plc 5.2.5 R&D Analysis 5.3 BASF SE 5.3.1 Company Overview 5.3.1.1 Role of BASF SE in Nanotechnology for Food Packaging Market 5.3.1.2 Product Portfolio 5.3.1.3 Production Sites 5.3.2 Business Strategies 5.3.2.1 Product Development 5.3.3 Corporate Strategies 5.3.3.1 Partnership and Collaboration 5.3.3.2 Merger and Acquisition 5.3.4 Strength and Weakness of BASF SE 5.3.5 R&D Analysis 5.4 Chevron Phillips Chemical Company, L.L.C. 5.4.1 Company Overview 5.4.1.1 Role of Chevron Phillips Chemical Company, L.L.C. in Nanotechnology for Food Packaging Market 5.4.1.2 Product Portfolio 5.4.1.3 Production Sites 5.4.2 Strength and Weakness of Chevron Phillips Chemical Company, L.L.C. 5.5 Danaflex Nano LLC 5.5.1 Company Overview 5.5.1.1 Role of Danaflex Nano LLC in Nanotechnology for Food Packaging Market 5.5.2 Strength and Weakness of Danaflex Nano LLC 5.6 DuPont Teijin Films 5.6.1 Company Overview 5.6.1.1 Role of DuPont Teijin Films in Nanotechnology for Food Packaging Market 5.6.1.2 Product Portfolio 5.6.1.3 Production Sites 5.6.2 Business Strategies 5.6.2.1 Product Development 5.6.3 Corporate Strategies 5.6.3.1 Partnership and Collaboration 5.6.4 Strength and Weakness of DuPont Teijin Films 5.7 Honeywell International Inc. 5.7.1 Company Overview 5.7.1.1 Role of Honeywell International in Nanotechnology for Food Packaging Market 5.7.1.2 Product Portfolio 5.7.2 Corporate Strategies 5.7.2.1 Partnership and Collaboration 5.7.3 Strength and Weakness of Honeywell International 5.7.4 R&D Analysis 5.8 Klockner Pentaplast 5.8.1 Company Overview 5.8.1.1 Role of Klockner Pentaplast in Nanotechnology for Food Packaging Market 5.8.1.2 Product Portfolio 5.8.1.3 Production Sites 5.8.2 Business Strategies 5.8.2.1 Product Development 5.8.2.2 Market Developments 5.8.3 Strength and Weakness of Klockner Pentaplast 5.9 Mitsubishi Gas Chemical Company 5.9.1 Company Overview 5.9.1.1 Role of Mitsubishi Gas Chemical Company in Nanotechnology for Food Packaging Market 5.9.1.2 Product Portfolio 5.9.2 Strength and Weakness of Mitsubishi Gas Chemical Company 5.9.3 R&D Analysis 5.1 Nanocor 5.10.1 Company Overview 5.10.1.1 Role of Nanocor in Nanotechnology for Food Packaging Market 5.10.1.2 Product Portfolio 5.10.2 Strength and Weakness of Nanocor 5.11 PPG Industries 5.11.1 Company Overview 5.11.1.1 Role of PPG Industries in Nanotechnology for Food Packaging Market 5.11.1.2 Product Portfolio 5.11.2 Strength and Weakness of PPG Industries 5.12 Sealed Air 5.12.1 Company Overview 5.12.1.1 Role of Sealed Air in Nanotechnology for Food Packaging Market 5.12.1.2 Product Portfolio 5.12.1.3 Production Sites 5.12.2 Business Strategies 5.12.2.1 Product Development 5.12.3 Corporate Strategies 5.12.3.1 Merger and Acquisition 5.12.4 Strength and Weakness of Sealed Air 5.12.5 R&D Analysis 5.13 Sonoco Products Company 5.13.1 Company Overview 5.13.1.1 Role of Sonoco Products Company in Nanotechnology for Food Packaging Market 5.13.1.2 Product Portfolio 5.13.1.3 Production Sites 5.13.2 Business Strategies 5.13.2.1 Market Developments 5.13.3 Corporate Strategies 5.13.3.1 Partnership and Collaboration 5.13.3.2 Merger and Acquisition 5.13.4 Strength and Weakness of Sonoco Products Company 5.14 Tetra Laval International S.A. 5.14.1 Company Overview 5.14.1.1 Role of Tetra Laval International S.A. in Nanotechnology for Food Packaging Market 5.14.1.2 Product Portfolio 5.14.1.3 Production Sites 5.14.2 Business Strategies 5.14.2.1 Product Development 5.14.3 Corporate Strategies 5.14.3.1 Partnership and Collaboration 5.14.4 Strength and Weakness of Tetra Laval International S.A. 5.14.5 R&D Analysis 5.15 3M 5.15.1 Company Overview 5.15.1.1 Role of 3M in Nanotechnology for Food Packaging Market 5.15.1.2 Production Sites 5.15.2 Strength and Weakness of 3M

6 Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/aa4thx

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

See the original post:

Insights on the Nanotechnology for Food Packaging Global Market Analysis and Forecast to 2025 - GlobeNewswire

Read the Rest...

Nanotechnology: What is it and how does it improve CBD? – VolteFace Magazine

§ November 12th, 2020 § Filed under Nanotech Comments Off on Nanotechnology: What is it and how does it improve CBD? – VolteFace Magazine

There is just about any kind of CBD product you can think of there are edibles (with vegan options because why not?), oil tinctures, cosmetic and skin care products. There are even party favours and pet products with CBD as the main ingredient!

With these awesome and innovative products readily available in the market, its impossible not to get curious about CBD. And the first question you might have is does it really work?. As you go along you research, you might encounter an even newer word CBD Nano.

So what is CBD nano? What does it do and does it really work?

We are just as curious as you are. If you really want to know more about CBD nanotechnology, read on. You came to the right place.

In simple words, nanotechnology involves breaking down the size of anything to nanoscopic dimensions. It may sound easy but nope, it requires a highly scientific process on the molecular level.

In the case of cannabidiol, nanotechnology would shrink down a single molecule by 4440%!

You may be wondering why there is a need to go through this process if it is so complicated, so complex. The idea behind nanotechnology is that by shrinking the particles and breaking the compounds apart is that it can easily enter the body through the blood streams and reach the liver faster.

Is it working? Does the idea behind it translate well to results?

According to studies, the reason why breaking down or using nanotechnology in CBD is because of its lipophilic qualities. In principle, molecules could either be hydrophilic or lipophilic. Hydrophilic basically means that the particles connect themselves to water-based molecules. While the other one is an oil-based compound which is not soluble in water. CBD is lipophilic by nature.

Human bodies, being at 70% water, could have a hard time absorbing cannabidiol. Imagine pouring oil in a glass of water and expecting them to mix well. It takes time before the body can absorb the cannabidiol substance in the body. CBD in general is lipophilic and fights off water molecules that try to attach to it. So how will the body absorb cbd oil? Thats where nanotechnology comes in.

The cannabinoid when broken down to nanoparticles, acts differently with water molecules. There is more scientific explanation about the actual relations of these molecules. But the fact remains that by breaking CBD down to nanoparticle size, it attaches and binds easily with lipids and water molecules. This allows faster and easier absorption of cannabinoids. These nanoparticles make massive improvements in CBD inside the body.

The CBD, as an industry, has a great promise although it is in its early stages yet when it comes to research and studies.

What does nanotechnology mean when it comes to using CBD products? It simply means getting more from less. Aint that sweet?

Like everything in this world, be careful when choosing a nano CBD product. There are many companies who are over-promising this technology or worse, mislabeling their products. Check the label and the history of the company.

Nano CBD products could take the cannabidiol industry to greater heights if implemented properly. Were just excited as you are in this ever evolving world of CBD.

Right now, there are no various forms in how to take CBD. the right dosage and form will affect how your body will respond to it technology will help, of course. To make sure that CBD will work for you, it is still best to consult a healthcare professional.

Heather Smith is the Communications Manager at Sunday Scaries. Shes a composed copywriter and content strategist. Shes also a CBD advocate, promoting a healthy lifestyle free of stress and scaries.

See the original post:

Nanotechnology: What is it and how does it improve CBD? - VolteFace Magazine

Read the Rest...

Key Players In The Food Nanotechnology Market: Aquanova, Blue California, Frutarom Industries, Southwest Research Institute And Others – PRnews Leader

§ November 12th, 2020 § Filed under Nanotech Comments Off on Key Players In The Food Nanotechnology Market: Aquanova, Blue California, Frutarom Industries, Southwest Research Institute And Others – PRnews Leader

A new research study has been presented by Industrygrowthinsights.com offering a comprehensive analysis on the Global Food Nanotechnology Market where user can benefit from the complete market research report with all the required useful information about this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. The report discusses all major market aspects with expert opinion on current market status along with historic data. This market report is a detailed study on the growth, investment opportunities, market statistics, growing competition analysis, major key players, industry facts, important figures, sales, prices, revenues, gross margins, market shares, business strategies, top regions, demand, and developments.

The Food Nanotechnology Market report provides a detailed analysis of the global market size, regional and country-level market size, segment growth, market share, competitive landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunity analysis, strategic market growth analysis, product launches, and technological innovations.

Get a Free Sample Copy of the Food Nanotechnology Market Report with Latest Industry Trends @ https://industrygrowthinsights.com/request-sample/?reportId=172205

Major Players Covered in this Report are: Aquanova Blue California Frutarom Industries Southwest Research Institute

Global Food Nanotechnology Market Segmentation This market has been divided into Types, Applications, and Regions. The growth of each segment provides an accurate calculation and forecast of sales by Types and Applications, in terms of volume and value for the period between 2020 and 2026. This analysis can help you expand your business by targeting qualified niche markets. Market share data is available on the global and regional level. Regions covered in the report are North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Research analysts understand the competitive strengths and provide competitive analysis for each competitor separately.

By Types: Nano Materials Nano Tools Nano Devices

By Applications: Food Packaging Food Processing Food Testing Others

To get Incredible Discounts on this Premium Report, Click Here @ https://industrygrowthinsights.com/ask-for-discount/?reportId=172205

Global Food Nanotechnology Market Regions and Countries Level Analysis Regional analysis is a highly comprehensive part of this report. This segmentation sheds light on the sales of the Food Nanotechnology on regional- and country-level. This data provides a detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

The report offers an in-depth assessment of the growth and other aspects of the market in key countries including the US, Canada, Mexico, Germany, France, the UK, Russia, Italy, China, Japan, South Korea, India, Australia, Brazil, and Saudi Arabia. The competitive landscape chapter of the global market report provides key information about market players such as company overview, total revenue (financials), market potential, global presence, Food Nanotechnology sales and revenue generated, market share, prices, production sites and facilities, products offered, and strategies adopted. This study provides Food Nanotechnology sales, revenue, and market share for each player covered in this report for a period between 2016 and 2020.

Make an Inquiry of this Report @ https://industrygrowthinsights.com/enquiry-before-buying/?reportId=172205

Why Choose Us:

Table of Contents1. Executive Summary 2. Assumptions and Acronyms Used 3. Research Methodology 4. Market Overview 5. Global Market Analysis and Forecast, by Types 6. Global Market Analysis and Forecast, by Applications 7. Global Market Analysis and Forecast, by Regions 8. North America Market Analysis and Forecast 9. Latin America Market Analysis and Forecast 10. Europe Market Analysis and Forecast 11. Asia Pacific Market Analysis and Forecast 12. Middle East & Africa Market Analysis and Forecast 13. Competition Landscape

About Industrygrowthinsights: INDUSTRYGROWTHINSIGHTS has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info: Name: Alex Mathews Address: 500 East E Street, Ontario, CA 91764, US. Phone No: US: +1 909 545 6473 Email: [emailprotected] Website: https://Industrygrowthinsights.com

Read the original post:

Key Players In The Food Nanotechnology Market: Aquanova, Blue California, Frutarom Industries, Southwest Research Institute And Others - PRnews Leader

Read the Rest...

Global Conductive Ink Market 2020 Recovering From Covid-19 Outbreak | Know About Brand Players: Poly-ink, Novacentix, Creative Material, Parker…

§ November 12th, 2020 § Filed under Nanotech Comments Off on Global Conductive Ink Market 2020 Recovering From Covid-19 Outbreak | Know About Brand Players: Poly-ink, Novacentix, Creative Material, Parker…

Printed Circuit Boards

Get Chance of 20% Extra Discount, If your Company is Listed in Above Key Players List;https://inforgrowth.com/discount/5997660/conductive-ink-market

Impact of COVID-19:

Conductive InkMarket report analyses the impact of Coronavirus (COVID-19) on the Conductive Inkindustry. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 180+ countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Conductive Inkmarket in 2020.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; emergency declared in many countries; massive slowing of the supply chain; stock market unpredictability; falling business assurance, growing panic among the population, and uncertainty about future.

COVID-19 can affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets.

Download the Sample ToC and understand the COVID19 impact and be smart in redefining business strategies. https://inforgrowth.com/CovidImpact-Request/5997660/conductive-ink-market

Key Questions Answered in this Report:

What is the market size of the Conductive Inkindustry?This report covers the historical market size of the industry (2013-2019), and forecasts for 2020 and the next 5 years. Market size includes the total revenues of companies.

What is the outlook for the Conductive Inkindustry?This report has over a dozen market forecasts (2020 and the next 5 years) on the industry, including total sales, a number of companies, attractive investment opportunities, operating expenses, and others.

What industry analysis/data exists for the Conductive Inkindustry?This report covers key segments and sub-segments, key drivers, restraints, opportunities, and challenges in the market and how they are expected to impact the Conductive Inkindustry. Take a look at the table of contents below to see the scope of analysis and data on the industry.

How many companies are in the Conductive Inkindustry?This report analyzes the historical and forecasted number of companies, locations in the industry, and breaks them down by company size over time. Report also provides company rank against its competitors with respect to revenue, profit comparison, operational efficiency, cost competitiveness and market capitalization.

What are the financial metrics for the industry?This report covers many financial metrics for the industry including profitability, Market value- chain and key trends impacting every node with reference to companys growth, revenue, return on sales, etc.

What are the most important benchmarks for the Conductive Inkindustry?

Is there any query? Ask to our Industry Expert: https://inforgrowth.com/enquiry/5997660/conductive-ink-market

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT: Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA Contact Name: Rohan S. Email:[emailprotected] Phone: +1-909-329-2808 UK: +44 (203) 743 1898

More here:

Global Conductive Ink Market 2020 Recovering From Covid-19 Outbreak | Know About Brand Players: Poly-ink, Novacentix, Creative Material, Parker...

Read the Rest...

Nanotechnology in Medical Devices Market to Witness Exponential Growth || Leading Players 3M, Dentsply Sirona., Thermo Fisher Scientific Inc.,…

§ November 12th, 2020 § Filed under Nanotech Comments Off on Nanotechnology in Medical Devices Market to Witness Exponential Growth || Leading Players 3M, Dentsply Sirona., Thermo Fisher Scientific Inc.,…

The large scale Nanotechnology in Medical Devices Market research report recognizes and analyses the emerging trends along with major drivers, challenges and opportunities in the market. Following aspects are kept into view while formulating this global Nanotechnology in Medical Devices Market report and include the market type, organization size, availability on-premises, end-users organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific & Middle East & Africa. The market size, revenue generated from the sales and technologies by various application segments are also evaluated in this Nanotechnology in Medical Devices Market report. The report estimates 2020-2027 market development trends for industry.

Get Sample PDF (including COVID19 Impact Analysis) of Market Report @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nanotechnology-in-medical-devices-market&rp

Market Analysis and Insights of Global Nanotechnology in Medical Devices Market

Nanotechnology in medical devices market is expected to reach a market value of USD 20.52 billion by 2027 growing with the CAGR of 11.9% in the forecast period of 2020-2027. The increasing support of the government in the provision on advanced technology has been directly impacting the growth of nanotechnology in medical devices market.

The major players covered in thenanotechnology in medical devices marketreport are3M, Dentsply Sirona., Thermo Fisher Scientific Inc., PerkinElmer Inc, GENERAL ELECTRIC, Ferro Corporation, Eppendorf AG, Greiner Bio One International GmbH, ZELLMECHANIK DRESDEN, TV Rheinland, Medtronic, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, Demant A/S, Cochlear Ltd., Sonova, MED-EL, DEKRA, among other domestic and global players.Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Get Full TOC, Tables and Figures of Market Report @https://www.databridgemarketresearch.com/toc/?dbmr=global-nanotechnology-in-medical-devices-market&rp

Increasing geriatric population along with rising occurrences of diseases across the globe and growing adoption and need of high and advanced technology for the treatment of chronic diseases will accelerate the growth of the nanotechnology in medical devices market in the forecast period of 20202-2027. Rising number of applications from the emerging countries and advancement to technology for rich mid to late stage product pipeline will further create new opportunities for the growth of the market in the above mentioned forecast period.

Strict rules and regulations that will consume time in product approval and increasing process of nanotechnology based medical devices will hamper the growth of the market in the forecast period of 2020-2027.

This nanotechnology in medical devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info onData Bridge Market Researchnanotechnology in medical devices market contact us for anAnalyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Nanotechnology in Medical Devices Market Scope and Market Size

Nanotechnology in medical devices market is segmented on the basis of product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Nanotechnology in Medical Devices Market Country Level Analysis

Nanotechnology in medical devices market is analysed and market size insights and trends are provided by country, product and application as referenced above.

The countries covered in the nanotechnology in medical devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the nanotechnology in medical devices market because of prevalence of majority of nanotechnology based medical devices players and increasing government initiatives, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 because of increasing geriatric population, international research collaboration and increasing investment in research and development of nanotechnology.

The country section of the nanotechnology in medical devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Nanotechnology in medical devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nanotechnology in medical devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nanotechnology in medical devices market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Nanotechnology in Medical Devices Market Share Analysis

Nanotechnology in medical devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to nanotechnology in medical devices market.

Customization Available : Global Nanotechnology in Medical Devices Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-nanotechnology-in-medical-devices-market&rp

About Data Bridge Market Research:

Data Bridge Market Researchis a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us :

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475 Mail:Corporatesales@databridgemarketresearch.com

View original post here:

Nanotechnology in Medical Devices Market to Witness Exponential Growth || Leading Players 3M, Dentsply Sirona., Thermo Fisher Scientific Inc.,...

Read the Rest...

Nanotechnology in Medical Equipment Market 2020 Overview, Analysis,Growth Opportunities and Forecast to 2026 : Stryker Corporation, Dentsply…

§ November 12th, 2020 § Filed under Nanotech Comments Off on Nanotechnology in Medical Equipment Market 2020 Overview, Analysis,Growth Opportunities and Forecast to 2026 : Stryker Corporation, Dentsply…

Methodical research based conclusions drawn in the report presented by Orbis Pharma Reports on Nanotechnology in Medical Equipment market is designed and articulated on the basis of thorough analytical study, extensive research endeavors as well as minute detail compilation, prolonged observation that eventually result in optimal comprehension as well as systematic decoding of the Nanotechnology in Medical Equipment market. A thorough methodical research synopsis on the aforementioned Nanotechnology in Medical Equipment market based on Orbis Pharma Reports expert analysts suggest that this well-orchestrated documentation is an output of high end research initiatives and an amalgamation and flawless evaluation of a series of elements, events, triggers that are obtained by various tools that gradually shape the growth curve in global Nanotechnology in Medical Equipment market.

Get PDF Sample Copy of this Report to understand the structure of the complete report: https://www.orbispharmareports.com/sample-request/46788

This dedicated, well-planned report mindfully crafted by Orbis Pharma Reports is based on various market analytical tools such as PESTEL and SWOT analysis that thoroughly instigate strength and confidence in the potential marketing strategies that reciprocate and direct the Nanotechnology in Medical Equipment market towards optimistic growth in global Nanotechnology in Medical Equipment market.

Major Company Profiles operating in the Nanotechnology in Medical Equipment Market:

Stryker Corporation Dentsply International Thermo Fisher Scientific 3M Smith + Nephew Abbott AAP Implantate AG Starkey Hearing Technologies PerkinElmer, Inc. Mitsui Chemicals, Inc.

By the product type, the market is primarily split into:

Active Implantable Medical Equipments Biochip Portable Material

By the application, this report covers the following segments:

Treatment Using Diagnostic Using Research Using

A thorough review of drivers, restraints and challenges have been considered in detail to derive logical conclusions concerning future growth scope in the aforementioned market has also been pinned in this section of the report presented by Orbis Pharma Reports pertaining to Nanotechnology in Medical Equipment market.

The current status of the Nanotechnology in Medical Equipment market is thoroughly influenced by the current pandemic crisis of COVID-19 outbreak that has hit the market adversely, whereby several prominent economies are undergoing a massive transformation after having witnessed a sharp plummeting impact on growth prognosis in the past few months.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.orbispharmareports.com/enquiry-before-buying/46788

This ready-to-refer market presentation elaborating on various touchpoints about the Nanotechnology in Medical Equipment market is accurately designed and distributed by Orbis Pharma Reports highlighting prevalent market states and conditions, all in place to suit the best interests of the readers, such that enabling them to abandon previous notions and orchestrate new business deals, based on existing market status to ensure vigorous growth in Nanotechnology in Medical Equipment market.

As the report makes judicious advances based on aforementioned inferences about Nanotechnology in Medical Equipment market presented by Orbis Pharma Reports, backing upon best in industry practices, it carefully unfurls ample light on elements such as current, historic, as well as future growth rendering prospects characteristic to the market growth trends limited to Nanotechnology in Medical Equipment market.

The report presented by Orbis Pharma also involves crucial evidence based references on various market circumstances as well as protuberant segments encompassing type and applications that increase high end growth and revenue generation in the global Nanotechnology in Medical Equipment market in the forthcoming years.

Access Complete Report @ https://www.orbispharmareports.com/covid-19-impact-on-2020-2026-global-and-regional-nanotechnology-in-medical-equipment-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version/

About Us :

At Orbispharma we curate the most relevant news stories, features, analysis and research reports on the important challenges undertaken by the pharmaceutical and related sectors. Our editorial philosophy is to bring you sharp, focused and informed perspective of industries, the end users and application of all upcoming trends into the pharma sector. Orbispharma believes in conversations that can bring a change in one of the most crucial economic sectors in the world. With these conversations we wish our customers to make sound business decisions with right business intelligence.

Contact Us :

4144N Central Expressway, Suite 600, Dallas, Texas 75204, U.S.A. +1 (972)-362-8199 [emailprotected]

Original post:

Nanotechnology in Medical Equipment Market 2020 Overview, Analysis,Growth Opportunities and Forecast to 2026 : Stryker Corporation, Dentsply...

Read the Rest...

Global Nanometer Silver Market Innovations, Trends, Technology And Applications Market Report to 2020-2025 – TechnoWeekly

§ November 12th, 2020 § Filed under Nanotech Comments Off on Global Nanometer Silver Market Innovations, Trends, Technology And Applications Market Report to 2020-2025 – TechnoWeekly

The report covers key roles in analyzing the industry outlook and let understand the prominent vendors about their strategies and future plans for the betterment of the market in the near future. The Nanometer Silver Market is categorizing several segmentations including type, application, end user industry, and region. Furthermore, the report also covers an ultimate goal of market target gained on the basis of product or services. The Nanometer Silver Market let readers a clear eye-view about the regional growth and falls down mentioning about particular forecast period along with appropriate reasoning about the market. In this Nanometer Silver Market report, viewers can also experience detailed study of business introduction including benefits, restraints, opportunities, challenges, drivers, and more.

This study covers following key players: Key market players Major competitors identified in this market include Jinda Nano Tech, Cima NanoTech, Cline Scientific, Emfutur Technologies, Meliorum Technologies, NanoHorizons, Nanoshel, TANAKA KIKINZOKU KOGYO K.K, Applied Nanotech Holdings, Nanocs, etc.

Request a sample of this report @ https://www.orbischemreports.com/sample-request/82431

This effective set of information delivers an in-depth analysis about the drivers, challenges, market share, market dynamics, emerging countries, pricing, investment activity, industry performance, revenue generation and CAGR. The report covers key aspects including production, market share, CAGR, key regions, leading vendors, and revenue rates. The report also offers a major microscopic view at the market and identifies the footprints of the manufacturers with the help of understanding the Global revenue of vendors along with price and sales. The report studies about the demand coming from particular region and category of consumers taking interest in the product or services of the Nanometer Silver Market. The report manages to convey detailed information regarding prominent vendors of the Nanometer Silver Market including recent innovations, advancements, improvements, business estimation, revenue margin, and sales graph.

Market segment by Type, the product can be split into: Key market players Major competitors identified in this market include Jinda Nano Tech, Cima NanoTech, Cline Scientific, Emfutur Technologies, Meliorum Technologies, NanoHorizons, Nanoshel, TANAKA KIKINZOKU KOGYO K.K, Applied Nanotech Holdings, Nanocs, etc.

Market segment by Application, split into: [Application]

Access Complete Report @ http://www.orbischemreports.com/global-nanometer-silver-market-share-2020-industry-analysis-by-latest-trends-and-companies/82431/

The report smartly takes you to productive methodology in organizing, collection, and analyzing data. The research report is an overall draft when it comes to understand the investment structure and future analysis of the Nanometer Silver Market. Consumer-wise, the report studies about the demand coming from particular region and category of consumers taking interest in the product or services of the Nanometer Silver Market. This keyword report also provides viewers with relevant figures at which the Nanometer Silver Market was valued in the base year and estimated to project the revenue in the forecasted period. The Nanometer Silver Market reports delivers the information about market competition between vendors through regional segmentation of markets in terms of revenue generation potential, business opportunities, demand & supply comparison taking place in the future. The Nanometer Silver Market landscape and leading manufacturers offers competitive landscape and market development status including the overview of every individual market player.

For Enquiry before buying report @ https://www.orbischemreports.com/enquiry-before-buying/82431

About US: At OrbisChemReports, we bring you most updated information and excellent editorial analysis focusing on the chemical industry to help you take right business decisions. All our reports provide an unparalleled expertise on the industry movements covering all aspects of the market, key players and stakeholders.

Contact US: Hector Costello Senior Manager Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas 75204, U.S.A. Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

See the article here:

Global Nanometer Silver Market Innovations, Trends, Technology And Applications Market Report to 2020-2025 - TechnoWeekly

Read the Rest...

The Canadian connection to a promising COVID-19 vaccine – Ottawa Citizen

§ November 12th, 2020 § Filed under Nanotech Comments Off on The Canadian connection to a promising COVID-19 vaccine – Ottawa Citizen

Article content continued

Everybody is just delighted that it is looking so positive.

Canadian scientist Alan Bernstein, who is president and CEO of the global research organization CIFAR and a member of Canadas COVID-19 vaccine task force, likens lipid nanoparticles to small soap bubbles that protect the messenger RNA from degrading, facilitate getting it into cells, and enable it to act like a booster to the immune system.

Without lipid nanoparticles, there would be no RNA vaccines.

Madden has, in interviews, compared the delivery technology to a carrier for a fragile glass ornament getting delivered to your home. Not only would the carrier protect the ornament, it would let itself into the home, unwrap the package and leave the ornament, he said.

Vaccines that are based on messenger RNA are relatively new. The technology will get high-profile tests in the fight against COVID-19. Pfizer is not the only company whose experimental vaccine is based on the technology.

Moderna, which is also expected to report trial results soon, has also developed a RNA vaccine, as have others, including at least one Canadian vaccine.

Like other vaccines, those designed using messenger RNA trigger the body to produce an immune response, in this case to COVID-19. They do it by introducing a mRNA sequence (telling the cells what to build) that produces an antigen that triggers an immune response.

See the rest here:

The Canadian connection to a promising COVID-19 vaccine - Ottawa Citizen

Read the Rest...

Quantum Computing in the CloudCan It Live Up to the Hype? – Electronic Design

§ November 12th, 2020 § Filed under Quantum Computer Comments Off on Quantum Computing in the CloudCan It Live Up to the Hype? – Electronic Design

What youll learn:

Quantum computing has earned its place on the Gartner hype cycle. Pundits have claimed that it will take over and change everything forever. The reality will likely be somewhat less dramatic, although its fair to say that quantum computers could spell the end for conventional cryptography. Clearly, this has implications for technologies like blockchain, which are slated to support financial systems of the future.

While the Bitcoin system, for example, is calculated to keep classical mining computers busy until 2140, brute-force decryption using a quantum computer could theoretically mine every token almost instantaneously. More powerful digital ledger technologies based on quantum cryptography could level the playing field.

All of this presupposes that quantum computing will become usable and affordable on a widespread scale. As things stand, this certainly seems achievable. Serious computing players, including IBM, Honeywell, Google, and Microsoft, as well as newer specialist startups, all have active programs that are putting quantum computing in the cloud right now and inviting engagement from the wider computing community. Introduction packs and development kits are available to help new users get started.

Democratizing Access

These are important moves that will almost certainly drive further advancement as users come up with more diverse and demanding workloads and figure out ways of handling them using quantum technology. Equally important is the anticipated democratizing effect of widespread cloud access, which should bring more people from a wider variety of backgrounds into contact with quantum to understand it, use it, and influence its ongoing development.

Although its here, quantum computing remains at a very experimental stage. In the future, commercial cloud services could provide affordable access in the same way that scientific or banking organizations can today rent cloud AI applications to do complex workloads that are billed according to the number of computer cycles used.

Hospitals, for example, are taking advantage of genome sequencing apps hosted on AI accelerators in hyperscale data centers to identify genetic disorders in newborn babies. The process costs just a few dollars and the results are back within minutes, enabling timely and potentially life-saving intervention by clinicians.

Quantum computing as a service could further transform healthcare as well as deeply affect many other fields such as materials science. Simulating a caffeine molecule, for example, is incredibly difficult to do with a classical computer, demanding the equivalent of over 100 years of processing time. A quantum computer can complete the task in seconds. Other applications that could benefit include climate analysis, transportation planning, bioinformatics, financial services, encryption, and codebreaking.

A Real Technology Roadmap

For all its power, quantum computing isnt here to kill off classical computing or turn the entire world upside down. Because quantum bits (qubits) can be in both states, 0 and 1, unlike conventional binary bits that are in one state or another, they can store exponentially more information. However, their state when measured is determined by probability, so quantum is only suited to certain types of algorithms. Others can be handled better by classical computers.

In addition, building and running a quantum computer is incredibly difficult and complex. On top of that, the challenges intensify as we try to increase the number of qubits in the system. As with any computer, more bits corresponds to more processing power, so increasing the number of bits is a key objective for quantum-computer architects.

Keeping the system stable, with a low error rate, for longer periods is another objective. One way to achieve this is by cryogenically cooling the equipment to near absolute zero to eliminate thermal noise. Furthermore, extremely pure and clean RF sources are needed. Im excited that, at Rohde & Schwarz, we are working with our academic partners to apply our ultra-low-noise R&S SGS100A RF sources (Fig. 1) to help increase qubit count and stability.

1. Extremely pure and clean RF sources like the R&S SGS100A are needed in quantum-computing applications.

The RF source is one of the most important building blocks as it determines the amount of errors that must be corrected in the process of reading out the quantum-computation results. A cleaner RF signal increases quantum-system stability, reducing errors due to quantum decoherence that would result in information loss.

Besides the low phase and amplitude noise requirements, multichannel solutions are essential to scale up the quantum-computing system. Moreover, as we start to consider scalability, a small form factor of the signal sources becomes even more relevant. Were combining our RF expertise with the software and system know-how of our partners in pursuit of a complete solution.

Equipment Needs

In addition, scientists are constantly looking for new material to be applied in quantum-computing chips and need equipment to help them accurately determine the exact properties. Then, once the new quantum chip is manufactured, its resonance frequencies must be measured to ensure that no undesired resonances exist. Rohde & Schwarz has developed high-performance vector network analyzers (Fig. 2) for both tasks and can assist in the debugging of the quantum-computing system itself.

2. VNAs such as the R&S ZNA help determine properties of material used in quantum computing.

Our partners are relying on us to provide various other test-and-measurement solutions to help them increase the performance and capabilities of quantum computers. The IQ mixing is a crucial part of a quantum computer, for example, and our spectrum analyzers help to characterize and calibrate the IQ mixers and suppress undesired sidebands. Moreover, R&S high-speed oscilloscopes (Fig. 3) help enable precise temporal synchronization of signals in the time domain, which is needed to set up and debug quantum-computing systems.

3. High-speed oscilloscopes, for example, the R&S RTP, can be used to set up and debug quantum-computing systems.

As we work with our partners in the quantum world to improve our products for a better solution fit, at the same time were learning how to apply that knowledge to other products in our portfolio. In turn, this helps to deliver even better performing solutions.

While cloud access will enable more companies and research institutes to take part in the quantum revolution, bringing this technology into the everyday requires a lot more work on user friendliness. That involves moving away from the temperature restrictions, stabilizing quantum computers with a high number of qubits, and all for a competitive price.

Already, however, we can see that quantum has the potential to profoundly change everything it touches. No hype is needed.

Sebastian Richter is Vice President of Market Segment ICR (Industry, Components, Research & Universities) at Rohde & Schwarz.

Read more from the original source:

Quantum Computing in the CloudCan It Live Up to the Hype? - Electronic Design

Read the Rest...

The next 20 years: five new technologies on the horizon – MoneyWeek

§ November 12th, 2020 § Filed under Quantum Computer Comments Off on The next 20 years: five new technologies on the horizon – MoneyWeek

Its November 2040. You check your phone and see that youre due to meet a friend in New York for lunch. You get in your car and order it to drive to Heathrow. During the brief flight, you chat to your grandmother, who just celebrated her 100th birthday by running a marathon thanks to her new bionic leg. When you arrive in New York, another driverless car whisks you to the restaurant. While you wait at the bar, you scroll through the news: the World Health Organisation (WHO) says the seasonal flu has finally been eradicated. All this sounds like science fiction in 2020. But major advances in transport, medicine and quantum computing are set to revolutionise our lives.

One thing keeping carmakers managers awake at night is the decline in the number of young adults across the developed world learning to drive. According to Britains Department for Transport, the number of 17 to 20-year-olds with driving licences has fallen from around 50% in 1994 to just 29% in 2014. The trend is due to the rise in insurance costs and tougher tests. The good news is that in the future driving tests may become unnecessary thanks to the rise of cars that can drive without any human input.

Ben Barringer, an equity research analyst with Quilter Cheviot, thinks that fully autonomous cars are likely to take around eight to ten years to hit the mainstream. Real progress has been made in decreasing the amount of driver input needed. If automation is measured on a scale of zero to five, with five denoting total automation, an increasing number of carmakers offer level-two features such as automatic steering assistance and distance control, says Barringer.

Several companies are devoting large sums of money to designing cars that reach levels four and five. While none of these cars are commercially available yet, they are undergoing real-life testing on public roads across the world. They do occasionally make mistakes, but the number of miles they can travel without needing to be overruled by their human test-driver has been rising. Waymo (owned by Alphabet, Googles parent company) claims that its driverless cars travel an average distance of 13,000 miles per human intervention (more than the average Briton drives in a year). Chinas Baidu says its cars boast an average distance per human intervention of 18,000 miles.

One of the core technologies underpinning autonomous car technologies is Lidar, which measures the distance between two objects by using a combination of lasers and sensors. Infineon Technologies (Frankfurt: IFX) manufactures several key components used in Lidar systems, and should benefit from the rise of autonomous driving. It is on a 2021 price/earnings (p/e) ratio of 22 and yields 1.1%.

The way we travel longer distances also looks set to change. In the 1970s everyone expected Concorde to usher in a new age of supersonic travel. Sadly, while it was technologically advanced, it consumed a huge amount of fuel and made an extremely loud noise (which led to the US and other countries forcing it to stick to subsonic speeds as it flew through their airspace). As a result, demand suffered irreversible damage when oil prices surged in the 1970s. Concorde limped on until it finally retired from service in 2003.

Nonetheless, research over the past few decades into how supersonic travel can be made commercially viable is now starting to bear fruit. For example, Aerion Corporation claims to have developed a business jet in conjunction with General Electric that can fly as fast as Concorde while consuming much less fuel and being quiet enough to fly over land. They have already secured an order for 20 jets and hope to start selling them by 2026. Virgin Group and Japan Airlines have also agreed to buy a 75-seat passenger jet from rival Boom Supersonic.

While the possibility of supersonic travel is exciting enough, the real game-changer would be travel at a flight speed in excess of Mach 5 (five times the speed of sound and more than twice Concordes velocity). This would cut travel times between London and New York to 90 minutes, opening up the possibility of... day trips across the Atlantic, without having to bother about the need to adapt your body to different timezones, says Dr. Adam Dissel, president of Reaction Engines, one of the many companies researching this area. Dissel predicts that we will see not only supersonic passenger jets by the end of decade but also hypersonic ones within 20 years.

One firm heavily involved in efforts to develop both supersonic and hypersonic planes is engine maker Rolls-Royce (LSE: RR). It has a substantial equity stake in Reaction Engines and is also developing the engines for both Boom and Virgin Galactics supersonic jets as well. While the Covid-19-induced collapse in demand for air travel has caused its share price to plummet, a 2bn rights issue, along with government support, should enable it to ride out the crisis until demand recovers.

The idea of being able to travel from London to New York in less time than it takes to watch a football match is one thing, but at present most people are living under major restrictions on where they can go or what they do thanks to the ongoing pandemic. The good news is that the long-awaited Covid-19 vaccine may be only weeks away. According to the WHO, there are now 11 vaccines undergoing stage three-trials (the final pre-approval stage of clinical trials). These include vaccines developed in America, Europe, the UK, Russia and China, with a further 16 in stage two.

Of course, even after the Covid-19 pandemic ends there will be many diseases left to tackle. Alex Hunter of Sarasin & Partners notes that infectious diseases still account for one in every four deaths across the world. No wonder, then, that experts have calculated that every $1 spent by public bodies on vaccination programmes can yield a societal return of $44. More effective vaccines, against a wider range of diseases, with fewer side effects, could transform the world.

The way vaccines are produced is currently undergoing a revolution. Plant-based vaccines could slash the time it takes to manufacture a treatment, compared with the traditional approach using chicken eggs (finding a vaccine entails growing viruses in a cell, which they then take over, because they cant reproduce on their own). The elements of a vaccine build up much more quickly in plants than in eggs.

Meanwhile, vaccines that target the stem of a virus, rather than just its surface, means that the vaccine will still work even if the virus mutates, making a universal flu vaccine a possibility. Finally, so-called messenger RNA (MRNA) vaccines aim to improve the efficiency of the immune systems response by getting the body to create proteins that stimulate the immune system.

Vaccines are also playing an increasing role in treating diseases such as cancer. Drug companies are putting increasing resources into immunotherapy, which aims to train the bodys own immune system to turn against cancer calls. One company at the forefront of vaccines, both to prevent and treat disease, is biotechnology company Moderna (Nasdaq: MRNA). Not only is it one of the leaders in the race to bring a Covid-19 vaccine to market, but it is also working with Merck to develop personalised cancer vaccines based on MRNA technology.

Vaccines arent the only area of medicine experiencing a revolution. Artificial limbs have become much more sophisticated over the past decade, with the industry moving way from passive lumps of metal or plastic to prostheses that anticipate and support users movements. Whats more, exoskeletons, wearable robotic devices similar to the bionic suit in the Iron Man film series, are moving from science fiction to reality. Several companies now offer exoskeletons that give stroke victims, or those partially paralysed, a chance to walk again.

At present even the best prostheses work by either predicting what moves the user will make next or measuring activity in the nerves surrounding the missing limb. This can be a big problem if the user makes unexpected movements, or if there is something preventing the signal from the brain reaching the area (such as a break in the spinal cord). However, there has been much research on creating brain-computer interfaces that allow users to communicate with the devices through their thoughts alone.

One approach to producing brain-computer interfaces is through devices that measure signals in various parts of the brain and then decode them into messages that can be sent to the artificial limb. However, another approach is to develop computer chips that can be implanted directly into the brain. In August, Neuralink, one of Elon Musks many start-ups, demonstrated a device that had been successfully trialled in a pig. A stock to consider in the prosthetics sector is ReWalk Robotics (Nasdaq: RWLK), which offers a rigid exoskeleton for those who have damaged their spines as well as an exosuit for people undergoing therapy.

While the company is not yet profitable, it recently became an approved provider for Medicare (the public-health part of Americas insurance system), which has the potential to boost sales dramatically.

Medical advances have the potential to save lives and expand the human lifespan. However, attempts to use computers to speed up medical innovations by simulating human cells or even organs have been limited by the fact that even the fastest supercomputers struggle to carry out the complex calculations needed.

The good news is that quantum computers, which rely on energy on the scale of electrons and subatomic particles rather than the flow of electricity, may be able to help. Their unique properties allow them to tackle an enormous number of problems at the same time, unlike traditional computers, which tackle them one by one. The upshot is an exponential increase in computing power.

Drug and medical research isnt the only area that could be transformed by quantum computers. They could eventually deliver solutions to previously intractable problems, improve efficiencies and reduce costs across a broad range of industries, says Colm Harney of Sarasin & Partners. They could massively improve the management of transport networks, speed up development in machine learning, and lead to incredible new discoveries in the materials industry. Banks and engineering firms are also starting to explore potential applications of quantum computers.

Of course, building quantum computers that can tackle real-world problems is not going to be easy, warns Harney. Designers are still struggling with the task of keeping calculation errors to a minimum. Whats more, just building a quantum computer itself wont be enough, as the industry needs to develop an entire ecosystem of quantum-specific operating systems, software, algorithms, programmers and so on. Note that even after 40 years of research and development, quantum computing hasnt yet made a tangible difference to our lives.

Nevertheless, despite these previous disappointments there are some encouraging signs that the 2020s might be the decade that quantum computingfinally makes the leap from hype to reality, says Harney. Not only have Google and IBM built working quantum computers over the past 12 months, but there has been a step-change in the amount of private and public money invested this area. This includes 600m from the UK government, $1bn from the US, 2bn from the EU and $10bn from China, who all hope to become global leaders in this area.

Tom Weller of Evenlode Investment thinks that Microsoft (Nasdaq: MSFT) is one of the companies set to benefit from advances in quantum computing. Not only is the group developing quantum computers that can be accessed via the cloud, but they are also creating a range of applications that can exploit the extra processing power provided by quantum computers. The stock is on a 2022 p/e of 27.

More here:

The next 20 years: five new technologies on the horizon - MoneyWeek

Read the Rest...

Expert poses new theory on what really killed woman in Harper Woods jail – Detroit Free Press

§ November 12th, 2020 § Filed under Nano Medicine Comments Off on Expert poses new theory on what really killed woman in Harper Woods jail – Detroit Free Press

Autoplay

Show Thumbnails

Show Captions

The Wayne County Prosecutor's Office will ask an outsidemedical examiner to review the autopsy report of a woman who died earlier this year in the Harper Woods jail.

Priscilla Slater, 38, of Detroit, died inthe Harper Woods jail on June 10. Her deathprompted protests, the firing of two police officers for altering the police report detailing the discovery of her body, and the resignation of the city's longtimemayor after he told a meeting that he understood how someone could become a white supremacist.

Priscilla Slater, 38, of Detroit, died in the Harper Woods jail on June 10.(Photo: LaTasha Slater)

Slater was arrested around 1:30 a.m. on June 9 at the Parkcrest Inn in Harper Woods, after her boyfriend, Lewis Nichols, 27, also of Detroit, allegedly fired 18 shots into the parking lot.She died the next day.

The Michigan State Police investigated Slater's death. Their findings have been turned over to Wayne County Prosecutor Kym Worthy's office, which is conducting its own investigation.

A Wayne County Medical Examiner's report reached no certain conclusion about the cause of Slater's death. In the absence of pathological findings, the report speculated that an irregular heartbeat caused by abnormally angled coronary arteriescould have resulted in Slater's sudden death.

Protesters gather outside of Harper Wood Police Department while marching through Harper Woods for Priscilla Slater on July 24, 2020. Slater was found unresponsive in a Harper Woods Police Department holding cell in June 2020.(Photo: Ryan Garza, Detroit Free Press)

But Oakland County ChiefMedical Examiner Ljubisa J.Dragovic, M.D., who reviewed the autopsy report at the Free Press' request, calledthat theory "nonsense."

Because of the condition of Slater's liver, Dragovic said in an interview this week, "the most likely diagnosis that one can propose, without being able to see the details ofthe microscopic slides, is that she died from alcoholwithdrawal.If she was not monitored in the cell, thatis a big problem."

The autopsy report notes that video of the jail cell appears to show Slater having a seizure around 5:10 a.m. Her body was discovered in the cellmore than seven hourslater,at12:30 p.m.,

Oakland County (Mich.) Medical Examiner Ljubisa Dragovic.(Photo: ASSOCIATED PRESS)

The report does not state a time of death,but says the seizure may have occurred as Slater died.

Dragovic saidSlater's apparent seizure was not consistentwith the heart condition the Wayne County report says killed her.

"The presenting terminal events are not in concordance with a sudden onset of arrhythmia," he said.

Worthy said Wednesday that her office had not previouslybeen aware of the possibility that Slater died of alcohol withdrawal. Alcohol withdrawal is not mentioned in the Wayne County Medical Examiner's report.

"This information was not part of any investigation," she said. "Because of this new information, we feel we need to get an independent medical examinerto review the report."

Worthy added that the need to enlist an additional expert would delay the completion of her own office's report.

Edward Jouney, an addiction specialist an assistant clinical professor in the psychiatry department at Michigan Medicine, said jails should screen people who are in custody at intake to identify substance abuse and the risk of withdrawal. He noted he was speaking generally ofjail practices.

Demonstrators march down the streets of Harper Woods on July 15, 2020, demanding to know what happened to Priscilla Slater while she was in police custody. Slater was arrested by Harper Woods police and taken into custody on June 9, 2020.(Photo: Rodney Coleman-Robinson, Detroit Free Press)

"The first thing that should be done is to take a history to see if the individual has been using any alcoholor drugs, then quantify to see how much they're using," he said. "The body acclimates to drugs or alcohol, and experiences a change in physiology. When you go into jail, you're obviously not provided with alcohol. Thebody is going to react, and go into whats called alcohol withdrawal syndrome."

Most people, he said, will survive alcohol withdrawal with a minimum of care. But some will require medical treatment, and the condition can be life-threatening.

"Some people may necessitate admission to an ICU, and can experience severe problems. If they have a history of regular alcohol use, they [jailofficials]need to regularly assess them for symptoms of alcohol withdrawal."

It's unclear whether Slater was screened for drug or alcohol use, or if she was offered any treatment while in custody. The Wayne County Prosecutor's office denied a Freedom of Information Act request for police reports related to Slater's arrest and time in custody, citing the ongoing investigation.

LaTasha Slater, Priscilla Slater's sister, said Wednesday that Dragovic'sexplanation makes sense. Priscilla Slater worked hard, but she played hard, LaTasha said and that often meant drinking hard.

LaTasha had rejected the idea that her sister died of a previously undetected heart abnormality. But she said Dragovic's theory provides amore plausible explanation for her sister's death.

"That makes more sense to me that anything Ive heard about the whole situation," LaTasha said.

Nancy Kaffer is a columnist and member of the Free Press editorial board. She has covered local, state and national politics for two decades. Contact: nkaffer@freepress.com. Become a subscriber.

Read or Share this story: https://www.freep.com/story/news/local/michigan/wayne/2020/11/12/priscilla-slater-autopsy-jail-harper-woods/6251487002/

Read the original post:
Expert poses new theory on what really killed woman in Harper Woods jail - Detroit Free Press

Read the Rest...

[LOOK] The World’s Smallest 3D Printed Star Trek Spaceship and Boat – Science Times

§ November 12th, 2020 § Filed under Nano Medicine Comments Off on [LOOK] The World’s Smallest 3D Printed Star Trek Spaceship and Boat – Science Times

Scientists from Leiden University used 3D printing to produce microswimmers in the shape of the Star Trek spaceship, a boat, and other complex shapes that are too small to be seen by the naked eye. The boat, for example, measures one-third the thickness of the hair, SciTech Dailyreported.

These synthetic microswimmers are widely used in model systems to study out-of-equilibrium phenomena. Most synthetic microswimmers created in the past are spherical while biological microswimmers naturally go with different shapes and sizes.

Physicists Rachel Doherty, Daniela Kraft, and colleagues photographed the image of the microswimmers using an electron microscope. They published their study in the scientific journal Soft Matter.

The goal of the research is to understand biological microswimmers like bacteria, study author Samia Ouhajji said. Understanding them is vital in creating new drug delivery vehicles that can swim on their own and deliver medicine at the desired body part or organ inside the human body.

Microswimmers are small particles that can be followed through a microscope and are usually spherical, although the natural ones may come in different shapes and sizes that can move through liquid matter autonomously by interacting with their environment.

Although their name suggests that they swim, unlike most humans and animals, they do not have any limbs that they can use to propel or move them.

Artificial microswimmersare colloidal particles that are typically one to ten micrometers long that move on their own in the liquid using chemical reactions, wherein the platinum coating them reacts with the hydrogen peroxide solution which propels the micrometers through the liquid. In comparison, natural micrometers propel themselves by actuating appendages like cilia or flagella.

Ever since their discovery, scientists and non-scientists have been fascinated with the idea of microscopic vehicles that can move by themselves inside the body. It is even featured in some films like the 1966 science fiction movie entitled Fantastic Voyagewhich is about a group of scientists who shrank themselves and their submarine to save a colleague by removing the blood clot from his brain.

But it took decades for scientists to create artificial microswimmers using micro and nanofabrication technologies successfully. Now, there are already more than a dozen designs of microswimmers that have been created.

Read Also: Scientists Discover How Coronavirus Uses "Genome Origami" to Infect and Replicate Human Cells

The scientists discovered that they could print any shape of microswimmer using the 3D printerlike boats, ships, and other complex shapes. It helped them identify how each shape affects the motion of the swimming particles.

One of the study authors, Jonas Hoecht, decided to replicate the USSS Voyager from Star Trek because he was a fan of the hit science fiction movie, according to his colleague Ouhajji. He said that he promised Hoecht during the last week of their project that they would print any shape that he likes and chose the Star Trek spaceship.

Their study helped them understand how microswimmers could be used to clean wastewater or deliver medicine throughout the body and helps them learn more about biological swimmers like bacteria and sperm.

Read More: Meet Xenobots: World's First Living and Self-Healing Robots Using Stem Cells From Frog Embryos

Check out more news and information on Nanotechnology in Science Times.

Read more:
[LOOK] The World's Smallest 3D Printed Star Trek Spaceship and Boat - Science Times

Read the Rest...

Everyone Can Still Cast Their Votes For the Best Images Captured by FAU Researchers – Newswise

§ November 12th, 2020 § Filed under Nano Medicine Comments Off on Everyone Can Still Cast Their Votes For the Best Images Captured by FAU Researchers – Newswise

Newswise Florida Atlantic University is giving everyone the chance to cast their votes (again), but this time for the best images captured by its researchers in a contest that highlights work from across all of FAUs 10 colleges.

The goal of FAUs Art of Science photo contest, which is in its second year and comprised of two competitions, is to engage and educate the public in the unique study, scholarship and creative activities taking place in all of the Universitys labs, out in the fields and across all of its disciplines.

The Peoples Choice Award invites the public to select its favorite image among more than 30 finalists by voting here, with voting open until Nov. 30 at midnight. This is preceded by a contest where 13 judges from across the University chose three winners from more than 150 submissions. The winning photographs, including the 11 honorable mention winners, are here, and the top three winning photos can be downloaded via this link.

This year, Tricia Meredith, Ph.D., assistant research professor in FAUs College of Education and director of research and principle investigator for the FAU High School Imaging Lab, took first place with her microscopic image of a spiders spinnerets or silk-spinning organs. The photograph was captured in partnership with the Karen Slattery Educational Research Center for Child Development on FAUs Boca Raton campus.

Im honored that my photograph was selected from so many wonderful images, Meredith said. The lab is meant to be a collaborative research hub that provides mentorship for the students and this image is a great example of how it can help people understand the beauty of the natural world.

Imaging lab technicians scanned the spider in the garden habitat of the voluntary prekindergarten class so the children could discover there is more to the harmless spiny orb-weaver spider than just its scary-looking exterior.

Second place went to Charlene Fournier, a graduate student in the Charles E. Schmidt College of Science, for her picture of a male hybrid monkey born in a habituated mixed-species group between red-tailed monkeys and blue monkeys. Ongoing hybridization between these two species occurs in Gombe National Park, Tanzania, which provides a natural laboratory to study hybridization in the wild.

Third place belongs to Jasmine Coyle, a research program coordinator at FAUs A.D. Henderson University School, for her image of butterfly scales using the scanning electron microscope at the FAU High School Imaging Lab.

It is so beautiful and unique, said contest judge Gabby Barbarite, Ph.D., director of outreach and engagement for FAUs Harbor Branch Oceanographic Institute, about Coyles butterfly scales image. I had no idea butterfly scales looked like this, so not only was I surprised, but I learned something new.

- FAU -

About Florida Atlantic University: Florida Atlantic University, established in 1961, officially opened its doors in 1964 as the fifth public university in Florida. Today, the University, with an annual economic impact of $6.3 billion, serves more than 30,000 undergraduate and graduate students at sites throughout its six-county service region in southeast Florida. FAUs world-class teaching and research faculty serves students through 10 colleges: the Dorothy F. Schmidt College of Arts and Letters, the College of Business, the College for Design and Social Inquiry, the College of Education, the College of Engineering and Computer Science, the Graduate College, the Harriet L. Wilkes Honors College, the Charles E. Schmidt College of Medicine, the Christine E. Lynn College of Nursing and the Charles E. Schmidt College of Science. FAU is ranked as a High Research Activity institution by the Carnegie Foundation for the Advancement of Teaching. The University is placing special focus on the rapid development of critical areas that form the basis of its strategic plan: Healthy aging, biotech, coastal and marine issues, neuroscience, regenerative medicine, informatics, lifespan and the environment. These areas provide opportunities for faculty and students to build upon FAUs existing strengths in research and scholarship. For more information, visit fau.edu.

More:
Everyone Can Still Cast Their Votes For the Best Images Captured by FAU Researchers - Newswise

Read the Rest...

12 COVID-19 Autopsy Cases Reveal the TRUTH How Patients are Dying – Mega Doctor News

§ November 12th, 2020 § Filed under Nano Medicine Comments Off on 12 COVID-19 Autopsy Cases Reveal the TRUTH How Patients are Dying – Mega Doctor News

Mega Doctor News

In all 12 Coronavirus Autopsy cases, the cause of death was found within the lungs or the pulmonary vascular system. For the ones who did not die of large pulmonary emboli, they died of the extensive inflammation within the lungs, meaning pneumonia with ARDS. In these Coronavirus Autopsy cases, the lungs were wet and heavy, much like a sponge that is saturated with water. The surfaces of the lung often had a distinct patchy pattern, with pale areas alternating with slightly protruding and firm, deep reddish-blue Hypercapillarized areas. This is indicative of areas of intense inflammation, with endothelial dysfunction that can be seen at the microscopic level. When they look at slices of the lungs under the microscope, they found diffuse alveolar damage in 8 Coronavirus Autopsy cases. Specifically, they saw hyaline membrane formation, and tiny clots in the capillaries, and capillaries that were engorged with red blood cells, and other inflammatory findings. All these findings represent ARDS. They also found lymphocytes, a type of white blood cell, infiltrated these areas of infiltration. This fits the picture of viral pathogenesis.

They also looked at the pharynx of these COVID 19 patients, meaning in their throat. The lining of the throat, or mucosa, was hyperemic, meaning very red and irritated, and at the microscopic level, they saw lymphocytes invading there, which is consistent with a viral infection. In one Coronavirus case, a COVID patient had lymphocytes invade his heart muscle, findings that are consistent with what we call viral myocarditis. More than half of the COVID patients in this study had large blood clots. One-third of the COVID 19 patients had pulmonary embolism as the direct cause of death. All the others died of intense inflammation in their lungs related to pneumonia with ARDS (Acute Respiratory Distress Syndrome). Recently theres been studies showing that about 1/3rd of COVID patients with severe COVID have blood clots. In another study of 191 COVID patients with coronavirus aka COVID 19, half of those who died had clots, compared with 7% of survivors. And levels of D-dimer that were greater than 1000 g/L were associated with a fatal outcome. So its pretty clear now that the SARS-CoV-2 virus is causing a lot of clots to form in moderate to severe COVID disease.

How is this happening?

Its likely a combination of reasons, that has to do with downregulation of the ACE2 receptor in the lung alveoli, with a subsequent shift towards having more angiotensin II in the lungs, and less angiotensin 1-7 and 1-9 in the lungs, and when this happens, this leads to more cytokine storm with more inflammation, more constriction of pulmonary arteries, and more clots that develop. That, in turn, leads to more endothelial dysfunction in the capillaries that surround the alveoli. Also, there is evidence that the virus attaches to the ACE2 receptors of those endothelial cells that line those capillaries, which further propagates inflammation and clotting. And in the cytokine storm that develops there, RANTES, a chemokine, binds to the CCR5 receptor of CD4 and CD8 lymphocytes, and that causes those lymphocytes to infiltrate those areas of inflammation, and in doing so, further contributes towards the inflammatory reaction. This is why we are seeing low levels of CD4 and CD8 lymphocytes in severe COVID. Endothelial damage can also lead to the development of antiphospholipid antibodies, and these antibodies are bad because they trigger the formation of blood clots. Thats why Coronavirus patients who have clots with the diagnosis of antiphospholipid antibody syndrome need to be on blood thinners.

Also, 11 out of the 12 Coronavirus patients in this study had underlying heart disease and were obese. These are known risk factors not just for cardiovascular disease, but also known risk factors for endothelial dysfunction, and are known risk factors for COVID. So the big takeaways from the findings in this study are that most people who die of COVID 19, its primarily a lung problem. Either related to inflammation with ARDS and/or blood clots.

Antiphospholipid syndrome might be a commonality among patients with thrombosis in COVID patients.

Dr. Mike Hansen, MD

Internal Medicine | Pulmonary Disease | Critical Care Medicine

Read more from the original source:
12 COVID-19 Autopsy Cases Reveal the TRUTH How Patients are Dying - Mega Doctor News

Read the Rest...

Opening of VA Tech’s Animal Cancer Care / Research Center In Roanoke A Grand Occasion For Region’s Pets – The Roanoke Star

§ November 12th, 2020 § Filed under Nano Medicine Comments Off on Opening of VA Tech’s Animal Cancer Care / Research Center In Roanoke A Grand Occasion For Region’s Pets – The Roanoke Star

First-in-region radiation therapy

Experiencing the new cancer centers radiation therapy suite nicknamed The Vault is akin to walking onto the set of a sci-fi movie. Sounds are strangely muffled by concrete walls with an average thickness of 6 feet, special shielding, and other elements designed to allow this powerful therapy to be delivered safely. The floor alone was constructed of more than 400 cubic yards of concrete.

The Vaults centerpiece is a $3.28 million Varian linear accelerator, one of the most advanced linear accelerators in the country and one of only a handful at veterinary institutions that meets criteria certifying it for human use.

Radiation therapy, though long part of the standard-of-care treatment options for many forms of human cancer, has never before been available to pets in Southwest Virginia. In November, the center began offering the treatment, becoming the regions only radiation oncology service for pets.

Beyond advancing the treatment of cancer in companion animals, the centers imaging capabilities stand to provide valuable insights to veterinarians, biomedical engineers, and human medical researchers in the fight against cancerous tumors that are common to both dogs and people.

The advanced technology in imaging and radiation therapy in our new facility has so much potential, said radiation oncologist Ilektra Athanasiadi, an assistant professor in the Department of Small Animal Clinical Sciences. We are committed to pushing the boundaries through research in order to deliver even better outcomes.

For decades, chemotherapy, radiation, and surgery have been the go-to trio of cancer treatments. But if a current slate of clinical trials at the Animal Cancer Center is successful, bubbles and zapping can be added to the list.

One of the main goals of our lab is to defeat cancer using, yes, bubbles, said Eli Vlaisavljevich, an assistant professor in the Department of Biomedical Engineering and Mechanics in Virginia TechsCollege of Engineering.

Vlaisavljevich and his team have partnered with oncology clinicians at the Roanoke center for several pilot studies that use a novel technique called histotripsy, which focuses ultrasound beams to create bubbles inside a defined area. Since the technique doesnt involve heat, damage to surrounding tissues is effectively avoided.

To treat tumors, histotripsy can target cancerous cells with what we call bubble clouds generated by ultrasound. The bubble clouds are made up of microscopic areas of cavitation bubbles that destroy the cancerous tissue when they expand and collapse, Vlaisavljevich explained. Once the affected area is treated, the bodys immune system kicks in to mop up the damaged cells and, the researchers hope, stimulates an immune response that will inhibit metastasis.

At present, histotripsy is being tested in two clinical studies involving dogs. The first will use the technique to target osteosarcoma bone tumors, which are remarkably similar in humans and canines, while the second will treat dogs with soft tissue sarcomas. Although histotripsy has been studied in humans, there is little data on its use in dogs or on these tumor types.

The principal investigator of the osteosarcoma study, Joanne Tuohy, an assistant professor of surgical oncology and the new centers interim director, is excited that this technology has the potential to help humans with osteosarcoma, an acutely painful disease in both species. Over the past three decades, the prognoses for people and dogs have not improved significantly.

Patients both humans and dogs need new treatments, Tuohy said. With the help of engineers, patients, owners, clinicians, and referring practitioners, I hope our trial can help move research forward.

Another partnership with theDepartment of Biomedical Engineering and Mechanicslooks to perfect a device that employs electrical pulses to kill cancer cells.

Developed by Rafael Davalos, the L. Preston Wade Professor of Biomedical Engineering, the technology called High-Frequency Irreversible Electroporation, or H-FIRE, has been refined through longstanding collaborations with faculty at the veterinary college. H-FIRE has already been used successfully in equine and canine studies across a variety of tumor types.

Dervisis recently completed a pilot study using H-FIRE in dogs with liver cancer. Essentially, were zapping the tumor, he said. To use technical terms, we apply high-frequency electrical pulses to the cancerous tissue through a series of electrodes, which creates tiny openings in the cell membrane, ablating the targeted cells.

In light of the success of the pilot study involving liver tumors, the oncology group has opened a new round of clinical trials, expanding the number of canine patients and the types of tumors to be treated. The current studies are focused on pancreatic, brain, and lung tumors, all cancers that can be difficult to treat in both humans and dogs.

The importance of personal protective equipment and proper ventilation has become a familiar refrain during the COVID-19 pandemic. For researchers at the Animal Cancer Center, however, safety protocols for handling potentially contaminated materials and preserving indoor air quality have long been the order of the day. These protocols are, in fact, woven into the very fabric of the new facility.

Its universally known that chemotherapy can be hard on a patients body, causing such side effects as gastrointestinal problems and fatigue in both people and animals. Less frequently acknowledged is the potential harm that chemotherapy can have on those who administer it.

Compared to the kind of high?dose exposure that cancer patients receive, Klahn said, research has shown that chronic low-level exposure to chemotherapy actually may have increased risk for the people who administer it.

In response, Klahn and six other experts nationwide spearheaded an effort to raise awareness of the potential dangers surrounding the use of chemotherapy drugs in veterinary medicine. In 2019, the group drafted a consensus statement for the American College of Veterinary Internal Medicine. Drawing on that expertise, Klahn worked closely with the Roanoke centers construction team to ensure that the chemotherapy-delivery suite meets stringent safety guidelines.

The purpose-built space includes such features as special air-handling, an advanced biosafety cabinet, a three-room chemotherapy suite, and a secure hazardous waste disposal stream, making the center a national model for the safe handling and administration of chemotherapy.

Even as the spaces built-in features are crucial, the centers highly skilled faculty and staff realize that ongoing training and adherence to policy set the facility apart.

This conscientiousness is the lynchpin of the centers chemotherapy safety program. We have policies for everything: administration and delivery of chemo, storage and disposal of drugs, discharging pets, even educating owners on how to safely handle pet waste, Klahn said. We share responsibility for modeling good practices.

Treating veterinary cancer is not for the faint of heart. Pets shorter lifespans, coupled with the inherent lethality of many cancers, makes oncology a specialty that attracts those who are motivated to fight long odds. And for many clinicians and researchers, more of the same is just not good enough.

The cancers I focus on in my research have some of the direst prognoses in veterinary medicine. Many of these cancers, like osteosarcoma and pancreatic tumors, are also very aggressive in humans, said Tuohy, who is exploring new therapies for these deadly tumors. The survival expectation of dogs and people with osteosarcoma, as one example, hasnt improved in decades. Its such a painful cancer for patients and often highly metastatic.

In the face of such bleak prognoses, Tuohy still believes that abstract questions are less important than the lives of her patients. I think its important to hold on to the positive outcomes, she said, but also remember the cases where things didnt go well. We have to do that if were going to improve outcomes.

Tina Pegg, the owner of Bradford, an 11-year-old mountain cur mix, shares Tuohys outlook.

Bradford, a protective, quirky dog that, Pegg said, just showed up right before Thanksgiving in 2011, had a big personality. Diagnosed with a pancreatic tumor that metastasized to a lymph node, Bradford recently died after undergoing an experimental procedure on the tumor.

Although the outcome wasnt what was hoped for, Pegg understands the value of Bradfords treatment. Bradford was a trailblazer. He did what he had to do to contribute [to the advancement of science], and then he was ready to move on, said Pegg. I truly believe this was the right path for him.

As the new centers interim director, Tuohy is surrounded by a team that shares her commitment to improving outcomes for animals like Bradford. Joining Athanasiadi, Dervisis, and Klahn, three new veterinarians were recently hired, expanding the ranks of the 11 doctors, six technicians, and four staff members who support the centers operations.

Radiation and medical oncologist Keiko Murakami has distinctive credentials, having completed two demanding residencies: one in radiation oncology at Purdue University, and one in medical oncology at Auburn University.

Oncologic surgeon Brittany Ciepluch completed an internship at the University of Florida, a residency at Texas A&M, and a surgical oncology fellowship at Colorado State University.

Nick Rancilio, a radiation oncologist and researcher who arrived from Auburn University, focuses on stereotactic and hypofractionated radiation therapy, techniques designed to deliver precisely targeted radiation in fewer treatments.

In addition, a search for a permanent director to lead the growing team of cancer experts has been opened. Were hoping, said Tuohy, to find someone who is passionate about advancing the diagnosis, treatment, and prevention of cancer in pets, as well as promoting the principles of One Health to achieve progress in cancer care for animals and people.

Well prepared in the face of difficult and sometimes emotionally painful work, the oncology team at the Animal Cancer Center is committed to uncovering ways to extend and improve the quality of their patients lives. Like Tina Peggs description of her dogs journey, they, too, believe they are on the right path.

Written by Mindy Quigley, clinical trials coordinator in the veterinary colleges Department of Small Animal Clinical Sciences.

See original here:
Opening of VA Tech's Animal Cancer Care / Research Center In Roanoke A Grand Occasion For Region's Pets - The Roanoke Star

Read the Rest...

Big Boom in IT enabled Healthcare Market 2020-2027 | GE Healthcare, Johnson and Johnson Healthcare Systems, Inc., Siemens AG, Apple, Inc. – Global…

§ November 12th, 2020 § Filed under Nano Medicine Comments Off on Big Boom in IT enabled Healthcare Market 2020-2027 | GE Healthcare, Johnson and Johnson Healthcare Systems, Inc., Siemens AG, Apple, Inc. – Global…

IT enabled Healthcare Market report has recently added by Research N Reports which helps to make informed business decisions. This research report further identifies the market segmentation along with their sub-types. Various factors are responsible for the markets growth, which are studied in detail in this research report.

For an effective business outlook, the market study examines various global regions, such as North America, Latin America, Asia-Pacific, Japan, and India by considering different segments such as type, size, as well as applications. SWOT and Porters five analysis are also effectively discussed to analyze informative data such as cost, prices, revenue, and end-users.

Avail pdf Sample Copy @: https://www.researchnreports.com/request_sample.php?id=53965

Top Key Players:

GE Healthcare, Johnson and Johnson Healthcare Systems, Inc., Siemens AG, Apple, Inc., eHealth Technologies, AT&T Inc., Cerner Corporation, Aerotel Medical Systems, Ltd., AirStrip Technologies LP, McKesson Corporation, Koninklijke Philips N.V., E*HealthLine.Com, Inc., Allscripts Healthcare Solutions, Inc. and IMS Health Holdings, Inc.

The report also summarized the high revenue generated with market facts and figures across regions such as North America, Japan, Europe, Asia and India. We focus on the key issues needed to have a positive impact on the market, such as policy, international trade, and speculation and supply demand in the Global IT enabled Healthcare Market.

The research report has been evaluated on the basis of various attributes such as manufacturing base, products or services and raw material to understand the requirements of the businesses. Apart from the regional outlook, the report also draws attention to leading industry key players such as IT enabled Healthcare to understand the successful sales strategies of the businesses. Additionally, it also covers various factors such as IT enabled Healthcare which are demonstrated as significant market propellers. For better understanding of the fluctuating trends in businesses, analysts further also focus on various attributes such as IT enabled Healthcare that limit market growth.

Key Questions the Report Answers:

The report also covers in-depth explanations, competitive scenarios, and a broad product portfolio with a broad product portfolio of key players in Global Smart City Infrastructure Market and SWOT analysis adopted by competitors. This report provides Porter analysis, PESTEL analysis and market appeal to help you better understand macro and microscopic market scenarios.

Early Buyers will get Discount@: https://www.researchnreports.com/ask_for_discount.php?id=53965

Key Benefits for Stakeholders:

Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global IT enabled Healthcare Market. The feasibility of the new report is also measured in this research report. Reasons for buying this report:

Avail Detail Inquiry @ https://www.researchnreports.com/enquiry_before_buying.php?id=53965

Fundamental of Table of Contents:

About Us:

Research N Reports: Research N Reports is a new age market research firm where we focus on providing information that can be effectively applied. Today being a consumer-driven market, companies require information to deal with the complex and dynamic world of choices, where relying on a soundboard firm for your decisions becomes crucial. Research N Reports specializes in industry analysis, market forecasts and as a result getting quality reports covering all verticals, whether be it gaining perspective on current market conditions or being ahead in the cutthroat global competition. Since we excel at business research to help businesses grow, we also offer to consult as an extended arm to our services which only helps us gain more insight into current trends and problems. Consequently, we keep evolving as an all-rounder provider of viable information under one roof.

Contact: Sunny Denis (Sales Manager), (Research N Reports) 10916, Gold Point Dr, Houston, TX, Pin 77064, +1-510-420-1213, sales@researchnreports.com

http://www.researchnreports.com

Read more:
Big Boom in IT enabled Healthcare Market 2020-2027 | GE Healthcare, Johnson and Johnson Healthcare Systems, Inc., Siemens AG, Apple, Inc. - Global...

Read the Rest...

The Canadian connection to a promising COVID-19 vaccine – Nipawin Journal

§ November 12th, 2020 § Filed under Nanotechnology Journal Comments Off on The Canadian connection to a promising COVID-19 vaccine – Nipawin Journal

A small Canadian biotech company is playing a starring role in a COVID-19 vaccine whose positive early results made headlines this week.

On Sunday, pharmaceutical giant Pfizer and German company BioNTech announced that their RNA-based COVID-19 vaccine is more than 90 per cent effective, according to early data.

There are still many questions that need to be answered about the vaccine, which is one of dozens in development around the world.

But it has put Vancouver-based Acuitas Therapeutics, which developed the nanotechnology that enables the Pfizer vaccine to work, in the spotlight. Its contribution is the delivery system based on lipid nanoparticles that allows the messenger RNA to be safely delivered to its target.

President and CEO Thomas Madden, a world expert in the field of nanotechnology, said he and others at the company have been on tenterhooks waiting to see data from the clinical trials of the vaccine.

Everybody is just delighted that it is looking so positive.

Canadian scientist Alan Bernstein, who is president and CEO of the global research organization CIFAR and a member of Canadas COVID-19 vaccine task force, likens lipid nanoparticles to small soap bubbles that protect the messenger RNA from degrading, facilitate getting it into cells, and enable it to act like a booster to the immune system.

Without lipid nanoparticles, there would be no RNA vaccines.

Dr. Thomas Madden the president and CEO of Acuitas David Madden / jpg

Madden has, in interviews, compared the delivery technology to a carrier for a fragile glass ornament getting delivered to your home. Not only would the carrier protect the ornament, it would let itself into the home, unwrap the package and leave the ornament, he said.

Vaccines that are based on messenger RNA are relatively new. The technology will get high-profile tests in the fight against COVID-19. Pfizer is not the only company whose experimental vaccine is based on the technology.

Moderna, which is also expected to report trial results soon, has also developed a RNA vaccine, as have others, including at least one Canadian vaccine.

Like other vaccines, those designed using messenger RNA trigger the body to produce an immune response, in this case to COVID-19. They do it by introducing a mRNA sequence (telling the cells what to build) that produces an antigen that triggers an immune response.

The vaccines are generally faster and cheaper to produce than traditional vaccines, however RNA is fragile and needs to be protected. That is where nanotechnology comes in.

Madden said the carrier system technology was originally created with the hope that it could be used in gene editing. Over years, the technology, developed by a researcher at the University of British Columbia, has been improved and is now used for vaccines and therapeutics.

It is definitely Canadian and Canadians should take pride in the fact that they are contributing, said Madden.

Everyone at the small company which employs 29 people has been working since February to support efforts around the COVID-19 vaccine.

We are trying to compress many years of development work into a few short months, he said.

Madden said contributing to the vaccine effort has been rewarding.

Everybody has been impacted by COVID-19 to a lesser or a greater extent. What has been fantastic for my colleagues is that they have the feeling they are contributing toward the solution. The work is intended to help us emerge from this pandemic.

Bernstein said the lipid nanotechnology is one of the strong Canadian connections to research aimed at ending the pandemic.

The lesson here is about science and global collaboration.

View post:

The Canadian connection to a promising COVID-19 vaccine - Nipawin Journal

Read the Rest...

Insights on the Nanotechnology for Food Packaging Global Market Analysis and Forecast to 2025 – Press Release – Digital Journal

§ November 12th, 2020 § Filed under Nanotechnology Journal Comments Off on Insights on the Nanotechnology for Food Packaging Global Market Analysis and Forecast to 2025 – Press Release – Digital Journal

Dublin, Nov. 10, 2020 (GLOBE NEWSWIRE) -- The "Nanotechnology for Food Packaging Market - A Global Market and Regional Analysis: Focus on (Product, Application, Industry Outlook, Region and Country Analysis) - Analysis and Forecast, 2019-2025" report has been added to ResearchAndMarkets.com's offering.

The packaging industry is in the process of constant evolution, with various technological developments taking place in the industry that have enhanced features in packaging materials to make the food consumption experience better. The growing demand for food types and varieties of exotic foodstuffs leads to the complications for safer and more secure packaging of goods, which advances the concept of food packaging in the industry.

The rise of nanotechnology has accelerated the evolution of packaging present in the food industry. The packaging today has become the latest focus for food manufacturers, as they have to advance themselves in comparison to the new packaging material that acts as a part of branding and certifies food safety. An inevitable evolution is nanotechnology incorporated in food packaging, such as active packaging, improved packaging, and an upcoming category of smart/intelligent packaging that has sensors embedded in the packaging itself, which provides abundant data for suppliers to track than what today's packaging can offer.

The upcoming trends and opportunities in the nanotechnology application in food packaging sector are expected to be at the forefront in the coming decade, with blockchain application in food packaging becoming the most prominent in the field.

The exponential rise in the adoption of nanotechnology for food packaging on the global level has created a buzz among companies to invest in this industry.

On the basis of region, North America holds the largest share of nanotechnology for food packaging sold in terms of value, due to high awareness and product availability in the region. Apart from this, South America is anticipated to grow at the fastest CAGR during the forecast period.

Key Companies Profiled

Amcor Ltd., Sonoco Products Company, BASF SE, Tetra Laval International S.A., Honeywell International Inc., and Chevron Phillips Chemical Company, LLC, among others

Key Questions Answered in this Report:

Key Topics Covered:

1 Markets 1.1 Industry Outlook 1.1.1 Nanotechnology for Food Packaging: Overview 1.1.1.1 Timeline: Evolution of Food Packaging 1.1.1.2 Emergence of Nanotechnology in Food 1.1.2 Ecosystem Participants 1.1.3 Futuristic Trends 1.1.3.1 Blockchain in Food Packaging 1.2 Business Dynamics 1.2.1 Business Drivers 1.2.1.1 Need for Food Safety for the Consumers 1.2.1.2 Extended Shelf Life of Products 1.2.2 Business Challenges 1.2.2.1 Impact of COVID-19 on Raw Material Providers 1.2.3 Business Strategies 1.2.3.1 Product Development and Innovation 1.2.3.2 Market Developments 1.2.4 Corporate Strategies 1.2.4.1 Partnerships, Collaborations, Mergers and Acquisitions, and Joint Ventures 1.2.5 Business Opportunities 1.2.5.1 Nano-Printed Intelligent Food packaging

2 Application 2.1 Application and Specification 2.1.1 Fruits and Vegetables 2.1.2 Beverages 2.1.3 Prepared Foods 2.1.4 Meat Products 2.1.5 Bakery Products 2.2 Demand Analysis of Nanotechnology for Food Packaging (by Application) 2.2.1 Fruits and Vegetables 2.2.1.1 Demand Analysis of Fruits and Vegetables Nanotechnology for Food Packaging Market by Region 2.2.2 Beverages 2.2.2.1 Demand Analysis of Beverages Nanotechnology for Food Packaging Market by Region 2.2.3 Prepared Foods 2.2.3.1 Demand Analysis of Prepared Foods Nanotechnology for Food Packaging Market by Region 2.2.4 Meat Products 2.2.4.1 Demand Analysis of Meat Products Nanotechnology for Food Packaging Market by Region 2.2.5 Bakery Products 2.2.5.1 Demand Analysis of Bakery Products Nanotechnology for Food Packaging Market by Region

3 Products 3.1 Global Nanotechnology for Food Packaging Market (by Product) 3.1.1 Active Packaging 3.1.2 Improved Packaging 3.1.3 Smart/Intelligent Packaging 3.2 Demand Analysis of Nanotechnology for Food Packaging Market (by Technology) 3.2.1 Active Packaging 3.2.1.1 Demand Analysis of Active Packaging Market (by Region) 3.2.2 Improved Packaging 3.2.2.1 Demand Analysis of Improved Packaging Market (by Region) 3.2.3 Smart/Intelligent Packaging 3.2.3.1 Demand Analysis of Smart/Intelligent Packaging Market (by Region)

4 Regions 4.1 North America 4.2 South America 4.3 Europe 4.4 U.K. 4.5 Middle East and Africa 4.6 China 4.7 Asia-Pacific and Japan

5 Markets - Competitive Benchmarking & Company Profiles 5.1 Competitive Benchmarking 5.2 Amcor Plc 5.2.1 Company Overview 5.2.1.1 Role of Amcor Plc in Nanotechnology for Food Packaging Market 5.2.1.2 Product Portfolio 5.2.1.3 Production Sites 5.2.2 Business Strategies 5.2.2.1 Product Development 5.2.2.2 Market Development 5.2.3 Corporate Strategies 5.2.3.1 Partnership and Collaboration 5.2.3.2 Merger and Acquisition 5.2.4 Strength and Weakness of Amcor Plc 5.2.5 R&D Analysis 5.3 BASF SE 5.3.1 Company Overview 5.3.1.1 Role of BASF SE in Nanotechnology for Food Packaging Market 5.3.1.2 Product Portfolio 5.3.1.3 Production Sites 5.3.2 Business Strategies 5.3.2.1 Product Development 5.3.3 Corporate Strategies 5.3.3.1 Partnership and Collaboration 5.3.3.2 Merger and Acquisition 5.3.4 Strength and Weakness of BASF SE 5.3.5 R&D Analysis 5.4 Chevron Phillips Chemical Company, L.L.C. 5.4.1 Company Overview 5.4.1.1 Role of Chevron Phillips Chemical Company, L.L.C. in Nanotechnology for Food Packaging Market 5.4.1.2 Product Portfolio 5.4.1.3 Production Sites 5.4.2 Strength and Weakness of Chevron Phillips Chemical Company, L.L.C. 5.5 Danaflex Nano LLC 5.5.1 Company Overview 5.5.1.1 Role of Danaflex Nano LLC in Nanotechnology for Food Packaging Market 5.5.2 Strength and Weakness of Danaflex Nano LLC 5.6 DuPont Teijin Films 5.6.1 Company Overview 5.6.1.1 Role of DuPont Teijin Films in Nanotechnology for Food Packaging Market 5.6.1.2 Product Portfolio 5.6.1.3 Production Sites 5.6.2 Business Strategies 5.6.2.1 Product Development 5.6.3 Corporate Strategies 5.6.3.1 Partnership and Collaboration 5.6.4 Strength and Weakness of DuPont Teijin Films 5.7 Honeywell International Inc. 5.7.1 Company Overview 5.7.1.1 Role of Honeywell International in Nanotechnology for Food Packaging Market 5.7.1.2 Product Portfolio 5.7.2 Corporate Strategies 5.7.2.1 Partnership and Collaboration 5.7.3 Strength and Weakness of Honeywell International 5.7.4 R&D Analysis 5.8 Klockner Pentaplast 5.8.1 Company Overview 5.8.1.1 Role of Klockner Pentaplast in Nanotechnology for Food Packaging Market 5.8.1.2 Product Portfolio 5.8.1.3 Production Sites 5.8.2 Business Strategies 5.8.2.1 Product Development 5.8.2.2 Market Developments 5.8.3 Strength and Weakness of Klockner Pentaplast 5.9 Mitsubishi Gas Chemical Company 5.9.1 Company Overview 5.9.1.1 Role of Mitsubishi Gas Chemical Company in Nanotechnology for Food Packaging Market 5.9.1.2 Product Portfolio 5.9.2 Strength and Weakness of Mitsubishi Gas Chemical Company 5.9.3 R&D Analysis 5.1 Nanocor 5.10.1 Company Overview 5.10.1.1 Role of Nanocor in Nanotechnology for Food Packaging Market 5.10.1.2 Product Portfolio 5.10.2 Strength and Weakness of Nanocor 5.11 PPG Industries 5.11.1 Company Overview 5.11.1.1 Role of PPG Industries in Nanotechnology for Food Packaging Market 5.11.1.2 Product Portfolio 5.11.2 Strength and Weakness of PPG Industries 5.12 Sealed Air 5.12.1 Company Overview 5.12.1.1 Role of Sealed Air in Nanotechnology for Food Packaging Market 5.12.1.2 Product Portfolio 5.12.1.3 Production Sites 5.12.2 Business Strategies 5.12.2.1 Product Development 5.12.3 Corporate Strategies 5.12.3.1 Merger and Acquisition 5.12.4 Strength and Weakness of Sealed Air 5.12.5 R&D Analysis 5.13 Sonoco Products Company 5.13.1 Company Overview 5.13.1.1 Role of Sonoco Products Company in Nanotechnology for Food Packaging Market 5.13.1.2 Product Portfolio 5.13.1.3 Production Sites 5.13.2 Business Strategies 5.13.2.1 Market Developments 5.13.3 Corporate Strategies 5.13.3.1 Partnership and Collaboration 5.13.3.2 Merger and Acquisition 5.13.4 Strength and Weakness of Sonoco Products Company 5.14 Tetra Laval International S.A. 5.14.1 Company Overview 5.14.1.1 Role of Tetra Laval International S.A. in Nanotechnology for Food Packaging Market 5.14.1.2 Product Portfolio 5.14.1.3 Production Sites 5.14.2 Business Strategies 5.14.2.1 Product Development 5.14.3 Corporate Strategies 5.14.3.1 Partnership and Collaboration 5.14.4 Strength and Weakness of Tetra Laval International S.A. 5.14.5 R&D Analysis 5.15 3M 5.15.1 Company Overview 5.15.1.1 Role of 3M in Nanotechnology for Food Packaging Market 5.15.1.2 Production Sites 5.15.2 Strength and Weakness of 3M

6 Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/aa4thx

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Go here to see the original:

Insights on the Nanotechnology for Food Packaging Global Market Analysis and Forecast to 2025 - Press Release - Digital Journal

Read the Rest...

Scabies: the neglected tropical disease no one wants to talk about – The Conversation UK

§ November 11th, 2020 § Filed under Nano Medicine Comments Off on Scabies: the neglected tropical disease no one wants to talk about – The Conversation UK

Some diseases are more likely to enter public conversation than others. COVID-19 has dominated the public discourse in 2020, while cancer and AIDS are high-profile diseases that attract significant scientific and media attention. You can safely discuss these diseases around the dinner table. Other diseases, such as scabies, not so much.

Scabies is classed as a neglected tropical disease. Its out of sight and out of mind. But that doesnt mean it isnt there there will be an infestation somewhere near you take my word for it.

Scabies is caused by microscopic mites (Sarcoptes scabiei) that burrow under human skin and lay their eggs. The skin doesnt take kindly to this infestation, which leads to an angry, itchy rash.

There are an estimated 455 million cases of scabies globally every year. That burden is unequally distributed, with poorer countries bearing the brunt of infestations. Yet even in wealthy countries, where most neglected tropical diseases are unheard of outside of travel clinics, scabies is present, often appearing as outbreaks in institutional settings, such as care homes for the elderly.

It gets everywhere. While treatable, it is also stigmatised, under-reported, often misdiagnosed, and the itch can be seriously unpleasant to bear.

My team and I recently carried out research on scabies in Ghana, describing how patients with scabies and other skin infections would travel further than necessary to report to a health centre. They bypassed their nearest centre, often heading for clinics several kilometres away, across difficult terrain.

The reasons for this are unclear. Colleagues in rural Ghana suggested that the day of the week that the patient reported to a clinic coincides with market day, and so the patient may combine a visit to the clinic and shopping in their nearest town during the one visit. Our statistical analysis did not bear this out, and we could not exclude the idea that patients would bypass their nearest health centre for reasons of stigma.

Scabies is sometimes perceived as an unclean condition, even in the published literature, and the idea that washing is a cure is widespread. Bathing will not rid a patient of scabies but there are treatments that can clear it up.

In 2019, a huge outbreak of more than 6,000 cases of scabies occurred in the north-east region of Ghana. The media reported how there was locally widespread fear at the transmission of skin rashes between villagers. A combination of misdiagnosis and misinformation resulted in some infected people being temporarily banished from their homes.

Local journalists met some of the patients, describing them as having bloody open sores all over their bodies due to the excessive scratchings. The outbreak was later correctly diagnosed and treatment was provided. But transmission to thousands of people shows the potential for large outbreaks to occur. An Ethiopian outbreak covered 379,000 cases of confirmed scabies.

In developed countries, the true prevalence is often unknown, but the institutional outbreaks can have a major health, social and economic impact.

Our study in The Lancet showed how care home residents with dementia are more likely to end up with a scabies infection than those without dementia. Even in these settings of vulnerable populations, inequities still apply in terms of those most affected by infectious disease outbreaks.

Managing outbreaks in care homes is difficult and differs from how it is managed in other institutions, such as hospitals. A hospital ward is designed with infection control in mind, but care homes are quite literally that peoples homes.

The COVID-19 pandemic has put these issues in a very harsh light with the thousands of excess deaths in care homes in countries such as the UK, Sweden and elsewhere. Managing scabies in the elderly is also not helped by ill-founded safety concerns about one of the main oral medicines, ivermectin.

A 1997 correspondence in The Lancet reported increased mortality in care home residents being treated for scabies. It was immediately criticised for inadequate consideration of confounders (other factors that might have influenced the death of the resident, such as severity of dementia), and other outbreak reports have failed to confirm this association.

The WHO has endorsed ivermectin as safe and an essential medicine, but it remains unlicensed for scabies treatment in the UK and is rarely used despite being safe and effective. And, as an oral medicine, it is easier to use than skin creams, such as permethrin.

Scabies doesnt kill many people and it doesnt attract headlines, but dont underestimate the power of the itch. It makes life seriously unpleasant for those with the infection and can lead to stigma and poor quality of life. Multiply that one case you are thinking of by 455 million, and there you have the global annual picture.

See the article here:
Scabies: the neglected tropical disease no one wants to talk about - The Conversation UK

Read the Rest...

« Older Entries Newer Entries »



Page 6«..5678..2030..»